13F-HR filed by Venrock Adviser, LLC
Venrock Adviser, LLC filed this 13F-HR for the quarter ended 2020-03-31, filed 2020-05-15, with 16 holding rows worth $369,181,000.
- Accession
- 0001104659-20-062585
- Filer
- CIK 1615982
- Filed
- 2020-05-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2020
A holdings report, 16 entries on the cover page, a total value of $369,181,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $369,181,000 with VALUE read as thousands by filing date, 13F file number 028-20281. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| CONSTELLATION PHARMACEUTICALS INC. | 210373106 | Common Stock | 4,016,873 | $126,250,000 | thousands by filing date | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 810,000 | $47,652,000 | thousands by filing date | |
| RELMADA THERAPEUTICS INC | 75955J402 | COMMON STOCK | 842,814 | $28,748,000 | thousands by filing date | |
| TRILLIUM THERAPEUTICS INC COM NEW | 89620X506 | Stock | 6,790,000 | $27,432,000 | thousands by filing date | |
| 89BIO INC | 282559103 | COM | 952,200 | $24,043,000 | thousands by filing date | |
| INOVIO PHARMACEUTICALS INC | 45773H201 | COM NEW | 2,900,000 | $21,576,000 | thousands by filing date | |
| 10X GENOMICS INC CL A COM | 88025U109 | Stock | 300,000 | $18,696,000 | thousands by filing date | |
| Mersana Therapeutics Inc | 59045L106 | Common Stock | 2,623,903 | $15,297,000 | thousands by filing date | |
| MARINUS PHARMACEUTICALS INC | 56854Q101 | COM | 6,502,840 | $13,201,000 | thousands by filing date | |
| VERASTEM INC | 92337C104 | COM | 3,720,930 | $9,823,000 | thousands by filing date | |
| Adverum Biotechnologies, Inc. | 00773U108 | Common Stock | 994,381 | $9,715,000 | thousands by filing date | |
| IVERIC BIO INC | 46583P102 | COM | 2,586,537 | $8,898,000 | thousands by filing date | |
| AVADEL PHARMACEUTICALS, PLC | 05337M104 | COMMON STOCK-FO | 1,057,827 | $8,399,000 | thousands by filing date | |
| SIERRA ONCOLOGY INC | 82640U404 | CMN | 491,017 | $4,822,000 | thousands by filing date | |
| SPERO THERAPEUTICS INC | 84833T103 | COM | 474,015 | $3,830,000 | thousands by filing date | |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 113,140 | $799,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001104659-20-062585 | this filing | 2020-05-15 | acceptance time not in the bulk data set |